Clive Edelsten

Clive Edelsten

Auto-generated profile, based on publicly available information

Clive Edelsten

Great Ormond Street Hospital, London, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CEClive Edelsten
Clive Edelsten
MRM.AShwin Reddy
M.AShwin Reddy
MSMiles R Stanford
Miles R Stanford
EGElizabeth M Graham
Elizabeth M Graham

1 January 2002 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
CEClive Edelsten
Clive Edelsten
VLVickie Lee
Vickie Lee
CBChristopher R Bentley
Christopher R Bentley
JKJack J Kanski
Jack J Kanski
EGElizabeth M Graham
Elizabeth M Graham
Background/aims: The clinical course for childhood chronic anterior uveitis can vary from mild, self limiting disease to bilateral blindness. The purpose of this study was to identify those risk factors at onset that predict disease severity. Methods: A retrospective case note review of all patients with painless anterior uveitis diagnosed from 1982 to 1998. Patients were divided into two cohorts based on route of referral, diagnosis, and compliance with treatment. The standard cohort consisted of only those diagnosed from routine screening of juvenile idiopathic arthritis. Results: Complications—cataract surgery, ocular hypertension treatment, and visual acuity 6 months. Results—163 patients were included. 34 patients (21%) developed at least one complication. The most significant predictor of complications was severe disease at onset (p = 0.001). Other factors included uveitis at the first examination (p = 0.034), membership of the non-standard cohort (p = 0.0001), non-oligoarticular disease (p = 0.02), and late onset arthritis (p = 0.024). Male sex was associated with increased complications in the standard cohort (p = 0.001). Factors predisposing to remission included membership of the standard cohort (p = 0.003), onset after 1990 (p = 0.016), white race (p = 0.015), mild disease onset (p = 0.003), and a long gap between arthritis and uveitis onset (p = 0.015). Conclusions: It is possible to characterise the severity of those with childhood chronic anterior uveitis at the onset of disease. The majority of patients remit without visually disabling complications. It may be possible to reduce the complication rate by targeting aggressive immunosuppression on high risk patients before complications develop.

29 May 2013 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
PDF file
AHArnd Heiligenhaus
Arnd Heiligenhaus
CHCarsten Heinz
Carsten Heinz
CEClive Edelsten
Clive Edelsten
KKKaisu Kotaniemi
Kaisu Kotaniemi
KMKirsten Minden
Kirsten Minden
Juvenile idiopathic arthritis (JIA) is the most common systemic disease associated with uveitis in childhood. The frequency of JIA-associated uveitis (JIAU) varies geographically, and between ethnicities. Uveitis risk is high in JIA associated with oligoarthritis, young age at arthritis onset and ANA positivity. Gender alters risk for the incidence of JIA and the severity of JIAU. Familial cases support the possible role of genetic influences in the pathogenesis. Arthritis typically precedes the uveitis, but uveitis may occur up to seven years following the arthritis onset. Although complications still occur, the frequency of bilateral blindness has dropped, probably by both improved screening of high-risk patients with JIA, and the increased use of early immunosuppression. However, there is still continuing persistence of JIAU into adulthood. For improvement of epidemiological knowledge of this complicated disease, large, well-defined, long-term population-based registries are needed with the application of universally agreed case definitions and outcome measures.

1 June 2003 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
ACAudrey Chia
Audrey Chia
VLVickie Lee
Vickie Lee
EGElizabeth M Graham
Elizabeth M Graham
CEClive Edelsten
Clive Edelsten

9 January 2014 in Trials
Verified
Journal Article
Open access
PDF file
TGThe SYCAMORE Trial Management Group
The SYCAMORE Trial Management Group
ARAthimalaipet V Ramanan
Athimalaipet V Ramanan
ADAndrew D Dick
Andrew D Dick
DBDiana Benton
Diana Benton
SCSandrine Compeyrot-Lacassagne
Sandrine Compeyrot-Lacassagne
MBMichael W Beresford
Michael W Beresford
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with JIA are at risk of inflammation of the uvea in the eye (uveitis). Overall, 20% to 25% of paediatric uveitis is associated with JIA. Major risk factors for development of uveitis in JIA are oligoarticular pattern of arthritis, an age at onset of arthritis of less than seven years of age, and antinuclear antibody positivity. In the initial stages of mild to moderate inflammation the uveitis is asymptomatic. This has led to current practice of screening all children with JIA for uveitis. Approximately 12% to 38% of patients with JIA develop uveitis in seven years following onset of arthritis. In 30% to 50% of children with JIA-associated uveitis structural complications are present at diagnosis. Furthermore about 50% to 75% of those with severe uveitis will eventually develop visual impairment secondary to ocular complications such as cataract and glaucoma. Defining the severity of inflammation and structural complications in uveitis patients is now possible following Standardised Uveitis Nomenclature (SUN) guidelines, and modified to incorporate the consensus of end point and outcome criteria into the design of randomised trials. Despite current screening and therapeutic options (pre-biologics) 10% to 15% of children with JIA-associated uveitis may develop bilateral visual impairment and certified legally blind. To date, there remains no controlled trial evidence of benefits of biologic therapy.

27 August 2012 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
AHArnd Heiligenhaus
Arnd Heiligenhaus
IFIvan Foeldvari
Ivan Foeldvari
CEClive Edelsten
Clive Edelsten
JSJustine R. Smith
Justine R. Smith
RSRotraud K. Saurenmann
Rotraud K. Saurenmann
VSVibeke Strand
Vibeke Strand